Safety, immunogenicity, and immune persistence of two inactivated COVID-19 vaccines replacement vaccination in China: An observational cohort study - Wang, Xiaoqi; Deng, Yao; Zhao, Li; Wang, Lei; Fu, Zhenwang; Tang, Lin; Ye, Fei; Liu, Qianqian; Wang, Wenling; Wang, Siquan; Hu, Bo; Guan, Xuhua; et al. (Vaccine, 2022)
Keywords: Adolescent; Adult; adverse effects; Allergy and Immunology; Antibodies, Viral; Biological products; China; Clinical trials; Cohort analysis; Cohort Studies; Coronaviruses; COVID-19; COVID-19 - prevention & control; COVID-19 infection; COVID-19 vaccines; COVID-19 Vaccines - adverse effects; cytopathogenicity; Disease transmission; Epidemics; Humans; Immune persistence; Immunization; Immunogenicity; Immunogenicity, Vaccine; immunoglobulins; Inactivated vaccine; International standards; Medical laboratories; Middle Aged; Neutralization; Observational studies; Questionnaires; Regression analysis; Replacement vaccine; Safety; Sample size; SARS-CoV-2; seroprevalence; Severe acute respiratory syndrome coronavirus 2; Vaccination; Vaccines; Vaccines, Inactivated - adverse effects; Young Adult; Beijing China; China; COVID-19; Safety; Immune persistence; Immunogenicity; Replacement vaccine; Inactivated vaccine